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Abstract
De novo peptide sequencing from tandem MS data is a key technology in proteomics for
understanding the structure of proteins, especially for first seen sequences. Although this tech-
nique has advanced rapidly in recent years and becomes more effective, one crucial problem
remained unsolved. Due to the isomerism of leucine and isoleucine, they are practically in-
distinguishable in de novo sequencing using traditional tandem MS data. Some experimental
attempts have been made to resolve this ambiguity such as the EThCD fragmentation process.
In this study, we took a data-focused approach rather than only looking for characteristic satel-
lite ions produced by the EThCD fragmentation. We utilized cutting edge deep neural networks
to digest raw spectra data in a broader range searching for novel pieces of evidence in the spec-
tra in hopes to increase the reliability discriminating two isometric amino acids, while also
explored the capabilities of such tools when dealing with tandem MS spectra data.
Keywords: Tandam mass spectrometry, de novo sequencing, neural networks, deep learn-
ing
ii
Summary for Lay Audience
This research aims to provide a better solution to the problem of identifying two hard to
distinguish component in the protein sequence. Leucine and isoleucine have same molecular
mass so using traditional sequencing method that try to analyze the composition of a protein
sequence using mass spectrum data to tell these two amino acids apart would be impossible.
Recent advances in mass spectrometry have opened up new possibilities to create further evi-
dences in mass spectrum data that would be helpful to distinguish leucine and isoleucine and
those evidences have proven to be quite effective. In this research we carried out a series of
experiment feeding previously mentioned novel spectrum data into cutting edge deep neural
networks to further explore its capability and search for new evidence that may help us have a
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1.1 De novo peptide sequencing overview
The sequence information of biomolecules such as DNA, RNA, or protein is one the most
important intrinsic properties of that molecule and provides the entry point for understanding
the structural and functional properties of such molecules. Thus proper sequencing for theses
molecules is of great importance in biology-related researches. As for proteins, peptide se-
quencing via tandem mass spectrometry (MS/MS) is one of the most widely used tools in pro-
teomics for identifying and understanding proteins. The most direct sequencing approach using
MS/MS spectra is to utilize database search, i.e., relying on already known spectra database to
match new experimental spectra data. However, this database search method suffers from sev-
eral drawbacks and cannot be used for the identification of proteins from unknown genomes.
For the last two decades, de novo peptide sequencing methods via tandem mass spectrometry
have been explored thoroughly.[1, 2, 3, 4]
1.2 Tandem mass spectrometry
Tandem mass spectrometry, also known as MS/MS or MS2, is an experimental technique in
spectrometry analysis where more than two mass analyzers are connected together using an
additional reaction step to increase their abilities to analyze chemical samples’ masses.[5]
MS/MS analysis is commonly used in the analysis of big biomolecules, such as DNA and
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proteins.
The molecules of a given sample are ionized and the first spectrometer (MS1) separates
these ions by their mass-to-charge ratio (often denoted as m/z ratio). Ions of a particular m/z-
ratio coming from MS1) are selected and then made to split into smaller fragment ions, through
different physical or chemical processes like collision-induced dissociation, ion-molecule re-
action, or photodissociation. These fragments are then introduced into the second mass spec-
trometer (MS2), which again separates the fragments by their m/z ratio and records them. The
coupled fragmentation step makes it easier to identify and separate ions that have very similar
m/z ratios in regular mass spectrometers.
Figure 1.1 shows a typical proteomics tandem mass spectrometry experiment cycle: The
first step of this method is digestion of sample proteins from target cells or tissue into peptides
using proteolytic enzymes such as trypsin. Because the digestion process with trypsin produces
multiple peptides, the resulting peptide mixtures can be very complex. Peptide samples are then
separated by one- or multidimensional liquid chromatography (LC) and subjected to MS/MS
analysis to sequence the peptides. In quantitative proteomics, peptides are also encoded with a
stable isotope tag, which allows determination of the relative protein abundances with respect
to a control sample. Peptides are then ionized, and selected ions are subjected to sequencing
to produce signature MS/MS spectra[6]. The MS/MS data acquisition process consists of two
stages. The first stage involves reading all peptide ions that are introduced into the instrument
at any given time (MS spectrum). At the second stage, selected peptide ions (often referred
to as precursor or parent ions) are fragmented into smaller pieces (fragment ions) in the col-
lision cell of the mass spectrometer. Fragmentation of these precursor ions is fundamental to
MS/MS spectrometry and there are different methods used to fragment the ions and these can
result in different types of fragmentation and thus different information about the structure and
composition of the molecule. Most commonly used is the collision-induced dissociation(CID)
fragmentation and its high energy variant higher-energy collisional dissociation(HCD).[7] The
acquired MS/MS spectrum is thus a record of mass-to-charge ratios (m/z values) and intensities
of all the resulting fragment ions generated from an isolated precursor ion. The fragmentation
pattern encoded by the MS/MS spectrum allows identification of the amino acid sequence of
the peptide that produced it. After the desired amount of MS data is collected, the effort shifts
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toward the computational analysis.
Figure 1.1: Proteomics tandem mass spectrometry protocol[8]
In a typical MS/MS experiment, a single mass spectrometer can generate thousands of
MS/MS spectra per hour, and manual spectrum interpretation is not a viable option. As a result,
a number of computational approaches and software tools have been developed for automated
identification of peptide sequences according to MS/MS spectra[9]. Existing computational ap-
proaches can be roughly classified into three categories. In the first method, peptide sequences
are extracted directly from the spectra, i.e., without referring to a sequence database for help
(de novo sequencing approach)[2, 10, 3, 4]. In the second approach, peptide identification is
performed by correlating experimental MS/MS spectra with theoretical spectra predicted for
each peptide contained in a protein sequence database (database search approach)[11, 12, 13].
And a third approach is the hybrid of the previous two, namely those based on the extrac-
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tion of short sequence tags (three to five residues long) followed by error-tolerant database
searching[14, 15].
All of these three approaches have their own advantages and limitations. Usually, re-
searchers analyzing proteomic data are more interested in knowing what proteins are present in
the sample. This means that peptide sequences extracted from MS/MS spectra using de novo
algorithms need to be matched, e.g., using BLAST, against the sequences of known proteins
present in the sequence databases. In the high-throughput proteomics environment, researchers
are not always interested in, or have time to follow up on the peptides identified using de novo
sequencing tools and for which there is no exact match in the database (assuming the database
is fairly complete). As a result, the computational analysis typically starts with database search-
ing, and only then, if desired, de novo sequencing tools are applied to the remaining unassigned
spectra. However, the obvious advantage of the de novo sequencing approach over the database
search method is that it allows identification of peptides whose exact sequence is not recorded
in the existing sequence database. Even considering de novo peptide sequencing is computa-
tionally expensive and requires high-quality MS/MS spectra, it is nonetheless an indispensable
part of proteomics research.
1.3 De novo Peptide sequencing by MS/MS spectrum
During the MS/MS experiment, peptides are protonated in positive ion mode. The proton
initially locates at the N-terminus of the peptide or a basic residue side chain, but because of the
internal solvation, it can move along the sequence and break at different sites resulting in two
peptide fragments. The fragmentation rules are well explained by some publications.[16, 17]
Three different types of backbone bonds on the chain can be broken to form fragments: alkyl
carbonyl (CHR-CO), peptide amide bond (CO-NH), and aminoalkyl bond (NH-CHR). When
these backbone bonds break, six different types of sequence ions will be formed as shown in
Figure 1.2. The N-terminal charged fragment ions are denoted as a, b, or c ions, while the C-
terminal charged ones are denoted as x, y, or z ions. The subscript is the number of amino acid
residues. This notation was first proposed by Roepstorff and Fohlman, then Biemann modified
it and this became the most widely accepted version.[18, 19]
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Figure 1.2: 6 types of fragment ions in MS/MS peptide fragmentation, R1 ∼ R4 represent
organyl substituent or hydrogen. [20]
Among these residue ions, a, b, and y ions are the most common ion types, especially
in the low-energy collision-induced dissociation (CID) mass spectrometers, since the peptide
amide bond (CO-NH) is the most vulnerable and the loss of CO from b-ions. Double back-
bone cleavage produces internal ions, acylium-type like H2N CHR1 CO NH CHR2 CO
+
or immonium-type like H2N CHR3 CO NH
+ CHR4 (R1 ∼ R4 represent organyl substituent
or hydrogen). These ions are usually not abundant in the spectra. Further cleavage happens
under high-energy CID at the C-terminal residues, forming d, v, w ions[21], as shown in Figure
1.3
De novo is Latin means over again or anew. The de novo peptide sequencing is a method
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Figure 1.3: Satellite ions from high energy CID[21]
for peptide sequencing performed without prior knowledge of the amino acid sequence. This
method can obtain the peptide sequences without a protein database, which can overcome
the limitations of database-dependent methods like peptide mass fingerprinting (PMF). It uses
computational approaches to deduce the sequence of peptide directly from the experimental
MS/MS spectra. This method can be used for previously unsequenced organisms, antibodies,
peptides with posttranslational modifications (PTMs), and endogenous peptides.
For actual interpretation and computation, an amino acid fragment ion mass table like Table
1.1 will be used. The main idea of de novo sequencing is to use the mass difference between two
fragment ions to calculate the mass of an amino acid residue on the peptide backbone. The mass
can usually uniquely determine the residue. For example, a peptide sequence ‘ARNDC’ after
the high energy dissociation process could lead to b ions corresponding to sequence ‘ARN’
and ‘ARNDC’, the incremental mass difference between these two fragmented ions will be
Cysteine’s residue mass of 103 Da. And since this residue mass is the incremental difference
along the amino acid chain, the residue mass value is consistent for different fragmentation
process.
For the spectrum example shown in Figure 1.4, the mass difference between the y7 and
y6 ions in the spectrum graph is equal to 101 Da, which is the mass of residue Threonine.
Similarly, the next adjacent residue between y6 and y5 can be determined as Asparagine by the
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Name 3-Letter code 1-Letter code Residue mass Immonium Composition
Alanine Ala A 71.03711 44 C3H5NO
Arginine Arg R 156.10111 129 C6H12N4O
Asparagine Asn N 114.04293 87 C4H6N2O2
Aspartic acid Asp D 115.02694 88 C4H5NO3
Cysteine Cys C 103.00919 76 C3H5NOS
Glutamic acid Glu E 129.04259 102 C5H7NO3
Glutamine Gln Q 128.05858 101 C5H8N2O2
Glycine Gly G 57.02146 30 C2H3NO
Histidine His H 137.05891 110 C6H7N3O
Isoleucine Ile I 113.08406 86 C6H11NO
Leucine Leu L 113.08406 86 C6H11NO
Lysine Lys K 128.09496 101 C6H12N2O
Methionine Met M 131.04049 104 C5H9NOS
Phenylalanine Phe F 147.06841 120 C9H9NO
Proline Pro P 97.05276 70 C5H7NO
Serine Ser S 87.03203 60 C3H5NO2
Threonine Thr T 101.04768 74 C4H7NO2
Tryptophan Trp W 186.07931 159 C11H10N2O
Tyrosine Tyr Y 163.06333 136 C9H9NO2
Valine Val V 99.06841 72 C5H9NO
Table 1.1: Mass of amino acid fragment ions[16]
mass difference. This mass difference can usually uniquely determine the residue and such a
process can be continued until all the residues are determined.
However, the spectrum obtained from the mass spectrometry instrument does not tell the
ion types of the peaks. And sometimes the peptide fragment will have some modifications com-
ing out of the fragmentation process, for example, y and b ion fragments that contain the amino
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Figure 1.4: In a CID MS/MS, many copies of the same peptide are fragmented at the peptide
backbone to form b and y ions. The spectrum consists of peaks at the m/z (mass to charge)
values of the corresponding fragment ions. A good quality spectrum often contains many (but
not necessarily all) of the theoretical fragment ions.
acid residues Arginine, Lysine, Glutamine, and Asparagine may appear to lose ammonia(-17
Da). Y and b ion fragments that contain the amino acid residues Serine, Threonine, and Glu-
tamic acid may appear to lose water(-18 Da)[16]. Hence the sequencing process needs an
expert or a computer algorithm to figure out corresponding ions from the raw spectrum data
first. There are couples of software packages used for de novo sequencing, such as PEAKS[3],
Lutefisk[1], PepNovo[4], SHERENGA[2], etc..
As manual de novo sequencing is very labor-intensive and time-consuming, automated
algorithms or computer programs will usually be applied for the interpretation of spectra.
The initial and most straight forward approach to this problem is to list all possible sequence
combinations for the precursor peptide ion in the mass spectrum, and compare the theoretical
mass spectrum for each candidate configuration with the experimental result. The candidates
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that have a more similar spectrum will have a higher chance to be the right sequence. How-
ever, the number of possible amino acid sequence combinations may be exceedingly large. For
example, a precursor peptide with a molecular weight of 774 Da has 21,909,046 possible se-
quence configuration[22]. Even though this is achievable in modern computers, it still takes
too much time and isn’t practical for dealing with a large amount of through-out spectra data.
An improved method is called subsequencing, instead of considering all possible sequence
configuration of the prior, it only looks at short sequences of the prior that represent only a part
of the complete peptide. When sequences that highly match the fragment ions in the experi-
mental spectrum are found, they are extended by residues one by one to find the best matching
candidate.[23, 24]
Figure 1.5: Graphics display-oriented strategy for de novo sequencing[25]
A more efficient method applies graphical display in the spectra data. Fragment ions that
have the same mass differences of one amino acid residue are connected by lines. In this way,
it is easier to get a clear image of the ion series of the same type[25]. Figure 1.5 is an example
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of applying such a process. While this approach could be useful for manual de novo peptide
sequencing but is still undesirable for high-throughput computation.
The more successful and commonly used method is based on graph theory. The applica-
tion of graph theory in de novo peptide sequencing was first mentioned by Bartels[26]. Peaks
in the spectrum are transformed into vertices including a starting node and endpoint denot-
ing prior peptide ion mass in a graph called spectrum graph. And all the possible amino acid
masses form edges in this graph which means if two vertices have the same mass difference of
one or several amino acids, a directed edge will be applied. Then the sequencing problem is
transferred into finding the longest path in this spectrum graph. Previously mentioned software
packages all follow this basic idea. Dynamic programming has been proven to be an efficient
algorithm for solving this actual graph problem. Considering the paired nature of the frag-
mentation process, uni-directional dynamic programming won’t work properly here. Instead
the algorithm gradually “grow” a prefix(from b ions) and a suffix(from y ions) of the optimal
solution in a carefully designated pathway until the prefix and the suffix are sufficiently long to
form the optimal solution[3].
1.4 EThcD Discrimination of Isomeric Leucine/Isoleucine
For the past two decades, advancements in bioinformatic instruments and software have made
tandem mass spectrometry (MS) the method of choice for protein sequencing for its high effi-
ciency compared to traditional methods like Edman degradation. One crucial problem remains
unsolved: the core de novo sequencing idea is built upon identifying amino acid mass values
in the spectra while leucine and isoleucine are isomeric and have exactly the same molecular
mass. This has made the discrimination of these two amino acid residues almost impossible
in a common mass spectrometry process. Quite often in MS de novo results, they are marked
in peptide sequences with L/I or X signs. On the other hand, this discrimination may contain
invaluable information for the whole peptide sequence, particularly, for Ile/Leu residues in and
near complementary determining regions(CDRs) of an antibody, flipping between Ile/Leu may
result in significant differences in its biochemical properties[28].
Lots of efforts have been made over the years to resolve this problem using improved or
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Figure 1.6: Work flow for graph based peptide de novo sequencing[27]
specialized mass spectrometry techniques. As previously mentioned, further cleavage can hap-
pen using high energy CID creating more satellite ions apart from the six main types of residue
ions. The most straightforward method applies an additional high-energy collision activated
dissociation (HE CAD) step to introduce unique w ions from odd-electron z· ions. As shown in
Figure 1.7, Leucine and isoleucine residues will lose different amounts of mass (isopropyl vs
ethanol), which makes it possible for reliable identification of leucine vs isoleucine. Although
z· ions are rarely formed under CID conditions, they appear occasionally due to the statisti-
cal possibility of the cleavages of the corresponding bonds of the peptide chain, making this
CID-based approach successful to some extent.[29, 30] However, the resulting spectra are very
complex, while the targeted fragment ions peaks are of very low intensity or not observed at
all.
In 2014, Lebedev et al. utilized a similar concept and developed an ETD-HCD MS3 method
for Ile/Leu discrimination using an Orbitrap Fusion mass spectrometer equipped with electron
transfer dissociation (ETD) and high-energy collisional dissociation (HCD) functions. After
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Figure 1.7: Leu/Ile radical z ion residues forming different w ions. The · in the z-ion represents
a radical electron formed in the ETD process by the introduction of radical anions. The arrows
show the electron transfer process that follows the backbone fragmentation. The radical elec-
trons and neighboring chemical bonds in Leu/Ile z-ions behave differently causing the further
breakdown of C3H7 · and C2H5 · radicals and forming w-ions with different mass values.
the MS2 ETD fragmentation of the target peptide ions, an MS3 HCD fragmentation was carried
out for target z· ions with Ile/Leu residues for w ions observation.[31]. An example of this
method is shown in Figure 1.8. In general, the outcome spectra are very selective with 14
secondary fragment ions, with targeted w ions usually being the most abundant, resulting in an
effective discrimination for Ile/Leu. But this method is restricted by requiring the production
of critical z ions at the N-terminus which is not very common.
In 2016, Xiao et al. came up with a liquid chromatographymass spectrometry (LC-MS)
workflow that consists of multistage mass spectrometric analysis (HCD-MSn) and ETD-HCD
MS3 analysis strategy. [32] Each residue ion will be isolated separately and fragmented in MSn
mode (n = 2, 3, 4, or 5) either using ETD-HCD MS3 approach or, if it fails, producing the
corresponding immonium ion and triggering its fragmentation. A schematic representation of
this LCMS analysis strategy (decision tree) is listed in Figure 1.9. When only a single Ile/Leu
is present in the sequence, HCD MS3 fragmentation will cause the 86-Da immonium ion of
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Figure 1.8: MS3 HCD spectrum of z2+12 ion of brevinin 1E[31]
Leu or Ile to generate distinctive fragmentation patterns: fragmentation from Ile will give rise
to a high abundance of unique 69-Da ions by loss of ammonia, whereas the immonium ion
from Leu will only produce little (less than 10%) to no 69-Da ions.[33] Figure 1.10 showed an
example of this process. If there are more Ile/Leu instances in the sequence, ETD fragmentation
will be utilized to check on w ions production from Ile/Leu residues like previous studies. If
this also fails then further MS4 or even MS5 will be carried out until single Ile/Leu is left
on the sequence then a similar difference on 69-Da ions abundance will be used to give the
final answer. This method is suitable when the peptide sequence is already known (except for
Ile/Leu ambiguities) but will face limitations when doing de novo sequencing. Besides, MS4
and MS5 experiments may face sensitivity problems.
Lebedev et al. then came up with an improved ETD-HCD MS3 method that avoids the iso-
lation of z ions. This procedure involves Electron-Transfer/Higher-Energy Collision Dissocia-
tion(EThcD) approach introduced by Frese et al.[34] instead of ETD-HCD used in previously
mentioned studies.[35] EThcD is a 2-fold fragmentation process combining electron transfer
and higher-energy collision dissociation that generates dual fragment ion series and facilitates
extensive peptide backbone fragmentation. After an initial electron-transfer dissociation step,
all ions including the unreacted precursor ions are subjected to collision induced dissociation
which yields b/y- and c/z-type fragment ions in a single spectrum.[34] This enables observing
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Figure 1.9: Multiple-stage LC-MS Ile/Leu discrimination schematic[32]
Figure 1.10: Example HCD MS3 analysis of peptides containing only one Ile/Leu[32]
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w ions from all Ile/Leu residues in a single sequence without the need of separating each indi-
vidual z ion. Due to limitation in the spectrometer instruments, whole EThCD spectrum has to
be split into several pieces, so-called “Broadband windows” using different normalized colli-
sion energy (NCE) levels as shown in Figure 1.11. It is worth noting that there is a possibility
to do HCD for the entire set of ETD products with certain types of equipment. In this case, all
Ile/Leu residues identification may be established in one shot.
Figure 1.11: Fragmentation of triply charged ion of m/z 754.0141 of 19-residued peptide EF-
NAETFTFHADICTLSEK (residues 525543 of HSA). (a) ETD spectrum with activation time
of 100 ms. (b) EThcD in m/z range from 250 to 750, NCE = 5. (c) EThcD in m/z range from
700 to 1300, NCE = 10 [35]
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1.4.1 Our data centric approach
All the methods mentioned in previous sections are fundamentally based upon mass spectrom-
etry experiments and have common limitations. The most obvious one is the heavy reliance
on the presence of z-ions with Ile/Leu residues at N-terminus in ETD/ETcaD spectra. If a
sequence contains multiple leucines and/or isoleucines, it is important that all the targeted z
ions would be visible in ETD/ETcaD spectra. If a z ion is absent it is impossible to obtain the
corresponding w ion, which will render the identification process fruitless. Besides most of the
unsuccessful Ile/Leu discrimination happened when dealing with z-ions of m/z beyond 2000
where the kinetic shift increases when a fragmenting molecule becomes more complex.[35]
Here, we would like to take a data-centric approach that utilizes statistical analysis and ma-
chine learning models that look at large amounts of EThCD spectrum data regardless of these
experimental constraints and see if any meaningful predictions can be made just by looking at
the spectrum data itself without knowing each individual spectra’s fragmentation situation in
the MS process.
Chapter 2
Data and methodology overview
2.1 Data and problem description
The EThCD data investigated here was kindly provided by Bioinformatics Solutions Inc.EThCD
spectra were obtained using Orbitrap Fusion Lumos Tribrid Mass Spectrometer. Raw EThCD
spectra data were obtained from antibody samples and preprocessed using PEAKS AB 2.0
software [?] and manually validated by biomedical experts. The resulting dataset is a list of
all the spectra (list m/z location and intensity pairs) and each spectrum’s amino acid sequence
ground truth obtained via other sequencing methods with leucine and isoleucine identified. We
can treat this as a binary classification problem with regard to leucine/isoleucine discrimina-
tion. And our focus here is to explore the possibility of extracting other characteristic features
from the spectra data other than characteristic w ion peaks and evaluate different models’ per-
formances.
2.2 Mthodology
2.2.1 Artificial Neural Network
One of the main purposes of this research is to investigate the viability of utilizing modern
artificial neural network models when handling peptide MS/MS spectra data.
Artificial neural networks are a set of machine learning algorithms, modeled loosely af-
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ter the human brain[36], that are designed to recognize patterns. They interpret sensory data
through a kind of machine perception, labeling, or clustering raw input. The patterns they rec-
ognize are numerical, contained in vectors, into which all real-world data, be it images, sound,
text or time series, are translated.[37, 38]
One of the earlier applications of such a concept is the multilayer perceptron (MLP), a
class of feedforward artificial neural network (ANN). An MLP consists of at least three layers
of nodes: an input layer, a hidden layer, and an output layer. Except for the input nodes,
each node is a neuron that uses a nonlinear activation function. MLP utilizes a supervised
learning technique called backpropagation for training.[39, 40] Its multiple layers and non-
linear activation distinguish MLP from a linear perceptron. It can distinguish data that is not
linearly separable.[41]
Figure 2.1: Simple MLP structure example
MLP was a popular machine learning solution in the 1980s, used in applications for diverse
fields such as speech recognition, image recognition, and translation software,[42] but there-
after faced strong competition from much simpler support vector machines.[43]. Interest in
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backpropagation networks returned due to the successes of deep learning. We will also explore
MLP’s capability in solving our discrimination problem.
Between 2009 and 2012, the recurrent neural networks (RNN) and deep feedforward neural
networks developed in the research group of Jrgen Schmidhuber at the Swiss AI Lab IDSIA
have won eight international competitions in pattern recognition and machine learning.[44, 45]
For example, multi-dimensional long short term memory (LSTM)[46, 47] won three competi-
tions in connected handwriting recognition at the 2009 International Conference on Document
Analysis and Recognition (ICDAR), without any prior knowledge about the three different
languages to be learned.
Variants of the back-propagation algorithm as well as unsupervised methods developed by
Geoff Hinton and colleagues at the University of Toronto opened up the possibility for training
deep, highly nonlinear neural architectures.[48]. Deep learning feedforward networks alternate
convolutional layers and max-pooling layers, topped by several pure classification layers. Fast
GPU-based implementations of this approach have won several pattern recognition contests.
Such neural networks also were the first artificial pattern recognizing algorithm to achieve
human-competitive or even superhuman performance[45] on benchmarks such as traffic sign
recognition (IJCNN 2012),[49] or the MNIST handwritten digits recognition problem[50].
Deep learning methods also saw applications in the peptide sequencing area in recent years.
For example, PepNovo, a probabilistic network modeling method for de novo peptide sequenc-
ing was developed in 2005 to determine whether the peaks observed in the mass spectrum are
more likely to have been produced under our fragmentation model than under a model that
treats peaks as random events.[4] DeepNovo introduced deep learning method into de novo
peptide sequencing from tandem MS data, achieving major improvement of sequencing accu-
racy over the state of the art methods and subsequently enables complete assembly of protein
sequences without assisting databases.[51]
In the research we present here, we tested two deep convolutional neural network (CNN)
structures that have proven to be immensely successful in the image recognition area: The deep
convolutional network for object recognition developed and trained by Oxford’s renowned Vi-
sual Geometry Group(VGG) which achieved very good performance on the ImageNet dataset.[52]
And residual neural network (ResNet) developed by Microsoft Research that utilizes skip con-
20 Chapter 2. Data and methodology overview
nections, or shortcuts to jump over some layers to achieve state-of-the-art performance in image
recognition tasks.[53]
2.2.2 Perfomance metrics
The Ile/Leu discrimination problem is a binary classification problem at its core. Hence two
major performance metrics are observed here to represent the quality of our trained models.
The F1 score (also F-score or F-measure) is a measure of a test’s accuracy in the statistical
analysis of binary classification. It considers both the precision p and the recall r of the test
to compute the score: p is the number of correct positive results divided by the number of all
positive results returned by the classifier, and r is the number of correct positive results divided
by the number of all relevant samples (all samples that should have been identified as positive).
It is calculated as the harmonic mean of precision and recall, it is defined as follows and reaches






= 2 · precision · recall
precision + recall
(2.1)
We chose F1 score here since the actual distribution of leucine versus isoleucine is slightly
unbalanced in the experiment data, and F1 score will have a better measure of such unbalanced
class distribution compared to direct accuracy calculation.
AUC score or “Area under the ROC Curve” is also used as a metric. A ROC curve (receiver
operating characteristic curve) is a graph showing the performance of a classification model at
all classification thresholds. This curve plots two parameters: true positive rate (TPR) or recall
and false positive rate (FPR) under different classification thresholds(the prediction probability
thresholds at which to consider as a positive prediction). Lowering the classification threshold
classifies more items as positive, thus increasing both false positives and true positives. The
following figure shows a typical ROC curve.
AUC measures the entire two-dimensional area underneath the entire ROC curve using in-
tegral calculus from (0,0) to (1,1). AUC provides an aggregate measure of performance across
all possible classification thresholds and is classification-threshold-invariant as opposed to F1
score which is calculated at a 0.5 threshold. It measures the quality of the model’s predic-
tions irrespective of what classification threshold is chosen. Combining these two performance
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Figure 2.2: ROC example
metrics, we will be able to properly evaluate the performance of our different models.
2.2.3 Model explanation using LIME
Since the deep neural network models investigated in this work take a segment of raw spec-
trum data as input without any prior assumption of knowledge about the spectrum. It will
function more or less like black boxes. To further illustrate how these models work on the
data, we used a software tool proposed by M.Ribeiro, et al. called Local Interpretable Model-
agnostic Explanations (LIME). LIME is a tool that can explain the predictions of any classifier
in an interpretable and faithful manner, by learning an interpretable model locally around the
prediction.[54] A schematic of applying this tool is shown in Figure 2.3. Figure 2.4 is a model
representing the underlying algorithm. The black-box models complex decision function f (un-
known to LIME) is represented by the blue/pink background, which cannot be approximated
well by a linear model. The bold red cross is the instance being explained. LIME samples
instances, gets predictions using f and weighs them by the proximity to the instance being ex-
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plained (represented here by size). The dashed line is the learned explanation that is locally
(but not globally) faithful.
Figure 2.3: Example of explaining machine learning model prediction using LIME. The model
shown here is trained on a dataset correlating patients’ personal status and symptoms to their
disease diagnosis. Using LIME we can not only get a prediction from the machine learning
model but also get information on why this prediction is made. In this toy example, Sneeze and
headache are portrayed as contributing to the ‘flu’ prediction, while ‘no fatigue’ is evidence
against it. With these, a doctor can make an informed decision about whether to trust the
models prediction.
Figure 2.4: Toy example to present intuition for LIME.
LIME takes an input case and samples around this input with perturbations and compute
the predictions on these pretreated samples to check how the perturbation made in each feature
input changes the final prediction. Then a measure on the correlation on each feature from the
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original input and original prediction can be inferred from this localized approximation, thus
an importance value can be given on each feature to represent its impact on the prediction using
this particular model.
This way we can hope to see if deep neural networks are able to make better predictions
using novel information from the spectrum or function as a check to see if the models are at
least able to pick up characteristic w ion peaks at previously discussed locations near the z ion
peak. Besides, if there are other characteristic features hidden in the spectrum data we should
also be able to have a hint using this analysis tool.
Chapter 3
Results
3.1 Statistics of the dataset
There are 119275 spectra in total. 76625 of them were produced from the EThCD process while
the reset 42650 come from the vanilla HCD fragmentation process without the electron transfer
process. Among the EThCD spectra, there could exist none or one or multiple Ile/Leu positions
in one single spectrum. Since Ile/Leu discrimination is our primary focus, the composition of
a peptide sequence should in theory have no effect on this and all previous experimental results
on this subject centered around the z· ion from the N terminus residue. The first step of our
data pre-processing is to extract all the z· ion and w ion information in these locations.
After extraction, there are in total 118189 such possible z· ion locations in all the EThCD
spectra. The Ile/Leu composition is 37.6% isoleucine and 62.4% leucine. Due to the uncer-
tainty of the w ion forming process, only less than 40% of the time either of the two w ions
actually is observed in the theoretical m/z location. A detailed composition of the data is listed
in Table 3.1. From now on we denoted wi and wl as the two different types of w ions associated
with isoleucine and leucine respectively (z· ion mass - 29 Da and z ion mass - 43 Da).
3.2 Baseline analysis
Since w ions’ existence is currently the only known reliable criterion when it comes to the iden-
tification of Ile/Leu using EThCD spectrum, a simple analysis can be carried out to check how
24
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Kind Total Count Leu % Ile %
Isoleucine 44411 0% 100%
Leucine 73778 100% 0%
Either wi or wl observed 41129 66.16% 33.84%
Neither wi nor wl observed 77060 60.43% 39.57%
wi observed 17343 28.07% 71.93%
wl observed 28829 87.99% 12.01%
Both wi and wl observed 5043 59.98% 40.02%
Total 118189 62.42% 37.58%
Table 3.1: Isoleucin/Leucine and w ions distribution in spectra data
well the information about these two w ions is in terms of identifying leucine and isoleucine
on cases where either of the two w ions is observed in the spectra. This will serve as a baseline
situation for our later experiments.
Straightforward OLS (ordinary least squares) regression on the wi and wl peaks existence
(as a Boolean variable)’s correlation with Ile/Leu classification (0 as Leu, 1 as Ile) showed
strong correlation. The result can be found in Table 3.2
Besides the existence of the two w ion peaks, their peak intensity, corresponding z ion
peak intensity, and w ion peak’s relative intensity to z ion peak are also selected as features for
supervised learning model training. A handful of different models such as SVM(support vector
machines), random forest, MLP(multiple layer perceptrons), gradient boosting machines are
tested. And they all perform very similarly, achieving an accuracy of about 88% to 89% on the
validation set. Although this is consistent with experimental researches mentioned in chapter
1, the fact that less than 35% of the EThCD experiments are able to actually yield w ions leaves
the other 65% of the cases in a random guess situation. Considering this, only a 71% overall
prediction accuracy is possible based on the information about w ions alone.
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coef std err t P > |t| coef internal
Intercept 0.5106 0.006 89.800 0.000 [0.499, 0.522]
wi peak exist[T.True] 0.3395 0.005 69.059 0.000 [0.330 , 0.349]
wl peak exist[T.True] -0.4499 0.005 -84.865 0.000 [-0.460 , -0.440]
Table 3.2: OLS regression result for wi and wl peaks existence. t is the value of the t-statistic
for testing if the corresponding coefficient is different from 0 (which corresponds to null-
hypothesis). P>|t| is the p-value for this hypothesis (coef!=0) test, a low p-value indicates
that the null-hypothesis can be rejected and the test hypothesis (coef!=0) should be accepted.
Coefficient interval is from 0.025 to 0.975.
3.3 Results on neural network based models
3.3.1 Data preparation
One of the best features of neural networks, especially deep neural networks, is their abilities
to self extract complex features from a very large raw input feature space without any prior
knowledge or assumption about the input data. However, if we only consider crucial MS/MS
peak locations, we are confined to only z ion peak and w ions peaks which is too small a feature
space if we want to utilize the power of neural networks. So the first step is to gather more
features or information from each data sample so that a complex neural network model can be
applied to fully match its potential.
Regardless of what machine learning model we use, one difficult aspect of using spectra
data as input is that the spectra data differ in length, depending on the length of the peptide
and the fragmentation situation, the spectra data can contain from less than 100 peaks to over
300 peaks. So in order to easily utilize machine learning models, the first step is to set a fixed
input dimensionality for varying input spectra length. In our research, we used a discretization
method applied to a fixed spectra interval described as follows.
The main idea of EThCD mass spectrometry is to create satellite ions from the N-terminus
z ion residues ending in Ile/Leu, then a natural approach is to focus on the mass range around
such theoretical location of the z ion in question. We set up a discretization grid centered
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around the theoretical z ion mass, [mz − mhw,mz + mhw] with an cell interval of mc. Then all
the mass spectrum peaks in the spectra that fall in this mass range will be discretizing into this
feature array Fm of 2mhw/mc length using the following equation:
Fm[⌊(mpeak−mz+mhw)·(1/mc)⌋] =
#
Intensitypeak,∀mpeak,mz−mhw ≤ mpeak ≤ mz+mhw (3.1)
Three pairs of mhw and mc values are chosen as an experiment setup: 50 Da half-width with
0.05 Da cell size, 100 Da half-width with 0.1 cell size, 200 Da half-width with 0.2 cell size.
These values are selected to balance two factors: if the width is too small, it won’t be able
to get the w ion peaks, if the width is too large, it will cover too much irrelevant information
with regards to current disputable Ile/Leu location. The size of the cell is kept in proportion
to the interval width to keep a consistent feature input shape while still maintaining sensitivity.
The resulting feature-length is kept at a fixed 2000 value in order to keep the model’s parameter
fixed while using different interval lengths. Separate training experiments were also done using
three different cell size on fixed interval length with results suggesting that these three cell sizes
choices won’t affect the model outcome due to the experimental sensitivity when obtaining
these MS spectra.
3.3.2 Initial investigation
Three different network structures were experimented on. The first one is a very simple mul-
tilayer perceptron (MLP), with just three hidden layers of 2000, 1000, and 200 perceptrons as
shown in Figure 3.1. The second and third networks are 1D convolution variants based upon
popular CNN network structures VGG net[52] and Resnet[53]. Their network structures are
listed in Figure 3.2 and Figure 3.3, respectively.
Activation function is one important aspect in artificial neural network structures, it is de-
signed to mimic the rate of action potential firing in the cell in biological neural networks. In
its simplest form, this function is binarythat is, either the neuron is firing or not. In practice
the activation function is usually a nonlinear function which introduces a non-linearity at zero
that can be used for decision making.[6] The nonlinearity also makes a network of more than
two layers a possible universal function approximator.[6] Relu activation layer, a non-linear
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rectifier activation function defined as f (x) = x+ = max(0, x) is chosen in our networks. Relu
is inspired by half-wave rectification in electrical engineering. The use of the rectifier as a non-
linearity has been shown to enable training deep supervised neural networks without requiring
unsupervised pre-training. Rectified linear units, compared to sigmoid function or similar ac-
tivation functions, allow faster and effective training of deep neural architectures on large and
complex datasets.[55]
Commonly used neural network techniques seen in these network structures include: Max-
pooling layer, a pooling technique aimed to accumulate features from maps generated by con-
volving a filter over an input. It is done in part to help over-fitting by providing an abstracted
form of the representation. As well, it reduces the computational cost by reducing the number
of parameters to learn and provides basic translation invariance to the internal representation.
Max pooling is done by applying a max filter to (usually) non-overlapping subregions of the
initial representation.[56] Dropout layer, a regulation mechanism that randomly disables cer-
tain portion of a layer of neuron connections to help with reducing overfitting and improving
generalization in deep neural networks.[56] Batch normalization, which normalizes the layer
input by re-centering and re-scaling is introduced in 2015, since then this technique has proven
to be very effective in improving the speed, performance, and stability of deep neural networks
as it may help mitigate the problem of internal covariant shift where parameter initialization and
changes in the distribution of the inputs of each layer affect the learning rate of the network.[57]
Figure 3.1: MLP network structure
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Figure 3.2: 1D VGG13 network structure
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Figure 3.3: 1D Resnet18 network structure
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For training, 20% of all the EThCD spectra locations were randomly selected as a validation
set with the rest 80% becoming the training set. As a sanity check, we also want to check if
the occurrence of w ions will be beneficial for the model as well as whether or not the model
can pick up this experimental feature without predetermined features. The validation set was
also divided into two parts: one with neither of the two w ions appearing denoted as v1 and the
other with either of them appearing in the spectra denoted as v2. Adam optimizer was applied
with an initial learning rate of 0.001, decreasing by a factor of 0.1 every 3 epochs over a total
of 12 epochs.
During training, training loss is calculated as cross-entropy loss and recorded for every
mini batch of 32 input vectors. Online training accuracy if calculated every 200 mini batches
and the online model is tested on validation data every 700 mini batches for validation accuracy
data. Validation is used to check on possible overfitting problem and make decision for training
epoch length. After 30 epochs of training on three different models, the validation performance
all plateaued after about 7 or 8 epochs, hence a final 12 epochs of training was chosen as a set
parameter for all training scenarios.
The resulting models and their performance are summarized in Table 3.3. And the detailed
training records and ROC curves for all nine models are listed in Figure 3.4 to Figure 3.12.
Training loss is calculated by applying model prediction score si to cross-entropy loss with








, i = 1, 2 (3.3)
Three ROC curves are listed for each model configuration, these curves are the result of
testing trained model on three differently conditioned validation sets: a set containing all spec-
tra where either of the two characteristic w ions is observed, a set containing all spectra where
no such information is present and these two sets as a whole. This separation is made mainly
to observe the model’s performance on picking up already known useful feature information
i.e., the two w ion peaks and its ability on data where this information is absent. This way we
can have a brief idea of whether or not the model is able to at least get useful information out
of the spectra and whether or no it discovered anything novel other than these two w ion peaks.
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A comparison of these resulting curves also is a good metric for evaluating different models’
performances.
Model v1’s F1 v1’s AUC v2’s F1 v2’s AUC Overall F1 Overall AUC
XGB baseline model 0.334 0.483 0.850 0.937 0.405 0.720
MLP, mhw = 50 0.603 0.796 0.901 0.981 0.708 0.884
MLP, mhw = 100 0.710 0.867 0.932 0.985 0.785 0.923
MLP, mhw = 200 0.809 0.925 0.952 0.991 0.856 0.956
VGG13, mhw = 50 0.617 0.822 0.929 0.988 0.727 0.904
VGG13, mhw = 100 0.653 0.804 0.915 0.985 0.737 0.892
VGG13, mhw = 200 0.787 0.925 0.947 0.993 0.840 0.957
Resnet18, mhw = 50 0.564 0.765 0.888 0.974 0.678 0.865
Resnet18, mhw = 100 0.408 0.749 0.875 0.967 0.592 0.854
Resnet18, mhw = 200 0.701 0.852 0.902 0.977 0.767 0.910
Table 3.3: F1 score, ROC AUC values on different part of the validation set from all the trained
model configurations.
At first glance, these neural network models are all very successful, not only achieved
much better performance on validation samples with w ion(s) with an almost precise predic-
tion but also come up with a somewhat reliable prediction even without the evidence from w
ion(s). However, when looked at carefully, it becomes worrisome that some form of overfitting
might have occurred. The MLP models while being the most simple structure outperform more
complex deep CNN networks, especially on the 200 Da half-width discretization input case.
Considering the sparse nature of the discretized spectra data(one spectrum usually contains
100 to 200 peak locations) , indeed there is little information available in each data entry thus
making it easier for the network to memorize the training input despite using anti overfitting
designs like the dropout layer, max pooling and batch normalization. Furthermore, the nature
of the MS/MS experiment leads to a single input sequence producing multiple spectra data
outcomes, which is very certainly a problem in our dataset. So a more sensible training setup
is to separate the training set and validation set randomly but separate them based upon their
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corresponding amino acid sequence and make sure that amino acid sequences corresponding
to the validation spectra won’t appear in the training set.
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Figure 3.4: Training statistics and final ROC curve from MLP model trained on a mhw = 50Da,
mc = 0.05Da spectra discretization input.
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Figure 3.5: Training statistics and final ROC curve from MLP model trained on a mhw = 100Da,
mc = 0.1Da spectra discretization input.
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Figure 3.6: Training statistics and final ROC curve from MLP model trained on a mhw = 200Da,
mc = 0.2Da spectra discretization input. Compared with Figure 3.4 and Figure 3.5, it is clear
that the larger input interval yields better performing model. Among the better performing
mhw = 200Da models in Figure 3.9 and Figure 3.12, it appeared that this MLP model performs
the best.
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Figure 3.7: Training statistics and final ROC curve from VGG13 model trained on a mhw =
50Da, mc = 0.05Da spectra discretization input.
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Figure 3.8: Training statistics and final ROC curve from VGG13 model trained on a mhw =
100Da, mc = 0.1Da spectra discretization input.
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Figure 3.9: Training statistics and final ROC curve from VGG13 model trained on a mhw =
200Da, mc = 0.2Da spectra discretization input. Compared with Figure 3.7 and Figure 3.8, it
is clear that the larger input interval yields better performing model.
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Figure 3.10: Training statistics and final ROC curve from Resnet18 model trained on a mhw =
50Da, mc = 0.05Da spectra discretization input.
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Figure 3.11: Training statistics and final ROC curve from Resnet18 model trained on a mhw =
100Da, mc = 0.1Da spectra discretization input.
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Figure 3.12: Training statistics and final ROC curve from Resnet18 model trained on a mhw =
200Da, mc = 0.2Da spectra discretization input. Compared with Figure 3.10 and Figure 3.11,
it is clear that the larger input interval yields better performing model.
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3.3.3 Improved training validation split
Instead of randomly shuffling the spectra data to get training and validation datasets, our second
round of training setup made sure that amino acid sequences for the spectra data in the training
set and validation set are mutually exclusive. This way, even if the model tends to overfit
and memorize some of the unique features related to specific amino acid sequences in the
training set, this in theory won’t contaminate the validation set anymore. The results are again
summarized in Table 3.4 and detailed training records can be found in Figure 3.13 to Figure
3.21.
Model F1 v1 ROC AUC on v1 F1 v2 ROC AUC v2 F1 ROC AUC
XGB baseline model 0.334 0.483 0.850 0.937 0.405 0.720
MLP, mhw = 50 0.458 0.680 0.812 0.940 0.588 0.796
MLP, mhw = 100 0.442 0.656 0.809 0.936 0.576 0.780
MLP, mhw = 200 0.557 0.734 0.824 0.938 0.653 0.823
VGG13, mhw = 50 0.457 0.707 0.839 0.955 0.600 0.820
VGG13, mhw = 100 0.497 0.706 0.847 0.956 0.624 0.820
VGG13, mhw = 200 0.599 0.782 0.858 0.958 0.690 0.861
Resnet18, mhw = 50 0.436 0.668 0.826 0.946 0.580 0.795
Resnet18, mhw = 100 0.450 0.648 0.817 0.936 0.582 0.779
Resnet18, mhw = 200 0.544 0.729 0.824 0.940 0.644 0.822
Table 3.4: F1 score, ROC AUC values on different part of the validation set from all the trained
model under a different configuration to combat validation set contamination
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Figure 3.13: Training statistics and final ROC curve from MLP model trained on a mhw = 50Da,
mc = 0.05Da spectra discretization input with exclusive training/validation AA sequence split.
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Figure 3.14: Training statistics and final ROC curve from MLP model trained on a mhw =
100Da, mc = 0.1Da spectra discretization input with exclusive training/validation AA se-
quence split.
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Figure 3.15: Training statistics and final ROC curve from MLP model trained on a mhw =
200Da, mc = 0.2Da spectra discretization input with exclusive training/validation AA se-
quence split. Compared with Figure 3.13 and Figure 3.14, it is clear that the larger input
interval yields better performing model.
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Figure 3.16: Training statistics and final ROC curve from VGG13 model trained on a mhw =
50Da, mc = 0.05Da spectra discretization input with exclusive training/validation AA se-
quence split.
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Figure 3.17: Training statistics and final ROC curve from VGG13 model trained on a mhw =
100Da, mc = 0.05Da spectra discretization input with exclusive training/validation AA se-
quence split.
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Figure 3.18: Training statistics and final ROC curve from VGG13 model trained on a mhw =
200Da, mc = 0.05Da spectra discretization input with exclusive training/validation AA se-
quence split. Compared with Figure 3.16 and Figure 3.17, it is clear that the larger input
interval yields better performing model. Among the better performing mhw = 200Da models
in Figure 3.15 and Figure 3.21, it appeared that this 1D VGG13 model performs the best.
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Figure 3.19: Training statistics and final ROC curve from Resnet18 model trained on a
mhw = 50Da, mc = 0.05Da spectra discretization input with exclusive training/validation AA
sequence split.
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Figure 3.20: Training statistics and final ROC curve from Resnet18 model trained on a
mhw = 100Da, mc = 0.1Da spectra discretization input with exclusive training/validation AA
sequence split.
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Figure 3.21: Training statistics and final ROC curve from Resnet18 model trained on a
mhw = 200Da, mc = 0.2Da spectra discretization input with exclusive training/validation AA
sequence split. Compared with Figure 3.19 and Figure 3.20, it is clear that the larger input
interval yields better performing model.
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The results suggest that serious memorization contamination in the validation is present in
the previous training setup. Training loss and accuracy are very consistent across two different
split setup while the validation metric is much worse once contamination is avoided. 1D VGG
network performed best in the end when the input interval is large enough, and those neural
networks all picked up Ile/Leu identification information contained in w ion peaks without a
predefined feature input to some extent which is evident from the performance improvement
when validated on v2 set, i.e., the set where w ion peaks are present. Besides, we did see a slight
improvement in data where neither of the w ion peaks is present and a slight improvement in
the overall performance on all kinds of data. However, the improvement is only marginal,
once we restrict the possible contamination in the validation set and there is no sign of other
significant identification features other than w ion peaks.
But in the end, there is still a big discrepancy between the training and validation perfor-
mance and the training performance stayed the same as previous setup. This suggests that
these models continued to memorize and overfitted some of the characteristic peaks unrelated
to distinguishing leucine and isoleucine in the training set. With the sequence information
completely separated in the validation set, however, we ended up with a better insight into
how these overfitted models would perform when they encounter spectra from unseen peptide
sequence source.
We also used LIME on our best performing model to test its reliability. The results are
listed in Figure 3.22. Four different input samples from the validation set were chosen to
represent different w ion configurations in the spectra. For example, Figure 3.22 (a) represents
an interpretation given by LIME when the trained VGG network makes prediction based on
a sample spectrum data entry with wl ion peak observed and wi ion peak unobserved. The
model predicts that the probability of the spectrum comes from a leucine location is 100%
and the following list of features is listed as the most impactful features from the 2000 long
input vector feature space. What LIME dose here is to perturb each of the 2000 features near
the input values and depending on how the prediction from the network responds to these
individual changes. The output from LIME showed that under this sample input, the model
weigh the spectrum location at z-29.0 and z-43.0 the most, and these two locations correspond
to the wi and wl ions. So the model considers the fact that wi ion peak is absent and wl ion peak
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(a) Spectrum input with wl ion peak observed (b) Spectrum input with wi ion peak observed
(c) Spectrum input with both w ion peaks absent (d) Spectrum input with both w ion peaks observed
Figure 3.22: LIME explanation results in four validation examples showing the prediction
made by VGG13 network and the top 5 feature(spectrum location relative to z ion peak)
contributing to the prediction with their respective feature importance to either a leucine or
isoleucine prediction.
is present contributes greatly to making the prediction that this is a leucine location rather than
isoleucine. The same logic applies to the reset 3 sample input examples showed in Figure 3.22.
The outcome confirms our previous thought that this trained model picked up those two
characteristic w ion peaks and can predict on this information. And it is fairly consistent across
all kinds of input that features in those two w ion peaks location have the most significant im-
pact on the final prediction while other features at different locations in the spectrum don’t show
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any kind of consistency which may also suggest that there is no other meaningful evidence in
the spectrum data to help with the discrimination of leucine and isoleucine.
Chapter 4
Conclusion and Discussion
Modern deep neural network structures are certainly powerful tools for extracting information
from large feature space. As shown in this work, they are capable of picking up the relevant
characteristic peak information in MS spectra data for discriminating leucine and isoleucine en-
coded in the w ions produced by EThCD peptide fragmentation without any prior knowledge of
where to look for these ions. Even though the achieved performance is only marginally better
than the baseline performance from models that only use predetermined features on informa-
tion about w ions, this research is still meaningful as it strongly suggests that w ions created
in the EThCD MS process is very likely the only reliable piece of evidence when it comes to
identifying leucine and isoleucine. The deep learning methodology might also become helpful
for detecting new fragmentation patterns which are not discovered from a traditional biochem-
istry view in peptide tandem mass spectrometry. Just as shown in this work, w ions’ correlation
to Leu/Ile separation in EThCD spectrometry can be discovered by just analyzing the spectra
data alone without knowing the underlying chemical or physical process that contributed to
this distinction.
Sadly despite some efforts to combat overfitting, the resulted models still memorized some
feature from the training set that didn’t generalize into making proper leucine/isoleucine clas-
sification. But our current results still performed better than doing classification using only w
ions information alone. In future research, the overfitting may be alleviated with more training
data.
On the other hand, this research also exposed some drawbacks of applying neural networks
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as a general-purpose supervised learning model. When dealing with sparse data like the ones
generated from raw MS spectrometry. Despite various counter mechanisms, neural networks
can still become very susceptible to overfitting and memorization problems since the training
data variance is limited compared to image or language data which gave rise to the most fas-
cinating application of deep learning models. Proper representation of MS/MS spectra data
when feeding into these neural networks also remains to be desired. In our research, we used
a very naive approach to discretize the spectra directly which didn’t yield any groundbreaking
result. This is imperative if we want to better utilize mature deep learning schematics that are
widely used in other areas.
Chapter 5
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